These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1973559)

  • 21. Pharmacology of amezinium, a novel antihypotensive drug. II. Examination of cardiovascular effects.
    Lehmann HD; Giertz H; Kretzschmar R; Lenke D; von Philipsborn G; Raschack M; Schuster J
    Arzneimittelforschung; 1981; 31(9a):1544-57. PubMed ID: 7197969
    [No Abstract]   [Full Text] [Related]  

  • 22. Idazoxan: a novel xylazine antagonist.
    Doherty T
    Vet Rec; 1985 Aug; 117(6):135. PubMed ID: 2864759
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.
    Elliott HL; Jones CR; Reid JL
    J Hypertens Suppl; 1983 Dec; 1(2):109-11. PubMed ID: 6152738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of single administration of adrenergic alpha receptor blockader piroxan on bronchial patency in patients with bronchial asthma].
    Zonis IaM; Zonis BIa
    Ter Arkh; 1981; 53(11):108-10. PubMed ID: 6122273
    [No Abstract]   [Full Text] [Related]  

  • 25. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
    Angel I; Niddam R; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased pressor responsiveness of femoral arteries to exogenous norepinephrine in renal hypertensive dogs mediated through alpha 2 adrenoceptors.
    Xu B; Chen RX; Chen DG
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):229-31. PubMed ID: 7901962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of drugs possessing antialcoholic activity on ethanol pharmacokinetics].
    Lelevich VV; Pron'ko PS; Liopo AV; Deniskovets AA
    Farmakol Toksikol; 1989; 52(4):85-8. PubMed ID: 2572455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal haemodynamics and the effect of alpha-adrenergic blockade in running and swimming splenectomized dogs.
    Joles JA; Huisman GH; Camphuisen G; Charbon GA
    Arch Int Physiol Biochim; 1983 Sep; 91(3):223-31. PubMed ID: 6198992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of idazoxan on tachycardia following electric stimulation of the thoracic sympathetic chain in the rat].
    Dabiré H; Fournier B; Schmitt H
    C R Seances Soc Biol Fil; 1986; 180(2):170-3. PubMed ID: 2877721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.
    Yamada S; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1980 Oct; 215(1):176-85. PubMed ID: 6109014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-adrenoreceptor reagents. 4. Resolution of some potent selective prejunctional alpha 2-adrenoreceptor antagonists.
    Welbourn AP; Chapleo CB; Lane AC; Myers PL; Roach AG; Smith CF; Stillings MR; Tulloch IF
    J Med Chem; 1986 Oct; 29(10):2000-3. PubMed ID: 2876101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]WB4101 labels S1 serotonin receptors in rat cerebral cortex.
    Norman AB; Battaglia G; Morrow AL; Creese I
    Eur J Pharmacol; 1984 Nov; 106(2):461-2. PubMed ID: 6152223
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacologic characteristics of pyrroxan].
    Krylov SS; Starykh NT
    Farmakol Toksikol; 1973; 26(4):396-9. PubMed ID: 4151295
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteers.
    Grasby PM; Begg EJ; Gartside SE; Cowen PJ
    Biol Psychiatry; 1989 Aug; 26(4):412-6. PubMed ID: 2569897
    [No Abstract]   [Full Text] [Related]  

  • 36. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
    Bakonyi A; Horváth EJ
    Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of pyrroxan and methylapogalanthamine on cerebral circulation and the brain's oxygen regime].
    Pogorelyĭ VE
    Farmakol Toksikol; 1981; 44(2):167-70. PubMed ID: 7274423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive drugs: proposed sites and mechanisms of action.
    Kaplan HR; Smith RD
    Fed Proc; 1981 Jun; 40(8):2268-74. PubMed ID: 6113170
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and antihypertensive properties of benzodioxane-pyridazinones and benzodioxane-dihydropyridazinones.
    Corsano S; Strappaghetti G; Codagnone A
    Arch Pharm (Weinheim); 1989 Nov; 322(11):833-5. PubMed ID: 2624530
    [No Abstract]   [Full Text] [Related]  

  • 40. Spiroxatrine: a selective serotonin1A receptor antagonist.
    Nelson DL; Taylor EW
    Eur J Pharmacol; 1986 May; 124(1-2):207-8. PubMed ID: 3720840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.